4//SEC Filing
BIOSPECIFICS TECHNOLOGIES CORP 4
Accession 0001062993-16-011353
CIK 0000875622operating
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 7:16 PM ET
Size
10.3 KB
Accession
0001062993-16-011353
Insider Transaction Report
Form 4
Wegman Thomas
DirectorPresident10% Owner
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2016-08-30−25,000→ 0 totalExercise: $0.83From: 2006-09-06Exp: 2016-09-05→ Common Stock, $.001 par value (25,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2016-08-30−100,000→ 0 totalExercise: $0.83Exp: 2016-09-05→ Common Stock, $.001 par value (100,000 underlying) - Exercise/Conversion
Common Stock, $.001 par value
2016-08-30$0.83/sh+25,000$20,750→ 212,549 total - Exercise/Conversion
Common Stock, $.001 par value
2016-08-30$0.83/sh+100,000$83,000→ 312,549 total
Footnotes (1)
- [F1]On September 6, 2006, the reporting person was granted an option to purchase 100,000 shares of the Issuer's Common Stock. The option vested in two equal installments based on the reporting person's satisfaction of two distinct performance conditions. The first performance related condition was satisfied on October 24, 2007, resulting in the vesting of the option as to 50,000 shares. The second performance related condition was satisfied on April 2, 2010, resulting in the vesting of the option as to the remaining 50,000 shares.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875622
Filing Metadata
- Form type
- 4
- Filed
- Aug 29, 8:00 PM ET
- Accepted
- Aug 30, 7:16 PM ET
- Size
- 10.3 KB